CN114631586A - Functional coffee and processing method thereof - Google Patents

Functional coffee and processing method thereof Download PDF

Info

Publication number
CN114631586A
CN114631586A CN202210342954.5A CN202210342954A CN114631586A CN 114631586 A CN114631586 A CN 114631586A CN 202210342954 A CN202210342954 A CN 202210342954A CN 114631586 A CN114631586 A CN 114631586A
Authority
CN
China
Prior art keywords
coffee
chlorogenic acid
freeze
functional
dried
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210342954.5A
Other languages
Chinese (zh)
Inventor
李书红
靳欣
杨诚
陈野
薛灵艳
修雨
李赫宇
王磊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enfen Technology Beijing Co ltd
Tianjin University of Science and Technology
Original Assignee
Enfen Technology Beijing Co ltd
Tianjin University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enfen Technology Beijing Co ltd, Tianjin University of Science and Technology filed Critical Enfen Technology Beijing Co ltd
Publication of CN114631586A publication Critical patent/CN114631586A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00Coffee; Coffee substitutes; Preparations thereof
    • A23F5/24Extraction of coffee; Coffee extracts; Making instant coffee
    • A23F5/36Further treatment of dried coffee extract; Preparations produced thereby, e.g. instant coffee
    • A23F5/40Further treatment of dried coffee extract; Preparations produced thereby, e.g. instant coffee using organic additives, e.g. milk, sugar
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00Coffee; Coffee substitutes; Preparations thereof
    • A23F5/24Extraction of coffee; Coffee extracts; Making instant coffee
    • A23F5/28Drying or concentrating coffee extract
    • A23F5/32Drying or concentrating coffee extract by lyophilisation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Tea And Coffee (AREA)

Abstract

The invention provides functional coffee based on chlorogenic acid and a processing method thereof, and the functional coffee comprises the following steps: step 1, shearing coffee concentrated solution by utilizing shearing equipment; step 2, freeze-drying the coffee concentrated solution after the shearing treatment to obtain freeze-dried coffee; and 3, mixing the freeze-dried coffee obtained in the step 2 with chlorogenic acid or a plant extract containing the chlorogenic acid to prepare functional coffee. After the coffee concentrated solution is subjected to shearing treatment, the solubility of functional component chlorogenic acid can be increased, and the dissolution speed of functional coffee is increased.

Description

Functional coffee and processing method thereof
Technical Field
The invention relates to the technical field of food production and processing, in particular to functional coffee based on chlorogenic acid and a processing method thereof.
Background
The freeze-dried coffee is instant coffee prepared by freezing a liquid product and removing ice through sublimation, the freeze-dried coffee sheet well keeps the original flavor of coffee, and the freeze-dried coffee sheet has a loose and porous internal structure, is high in dissolving speed, is convenient to measure, and can easily control the concentration of the obtained beverage.
Along with the increasing living standard of people, various functional freeze-dried coffees gradually come into the market, chlorogenic acid has wide biological activity, and the research on the biological activity of the chlorogenic acid by modern science is deeply carried out in a plurality of fields of food, health care, medicine, daily chemical industry and the like. Chlorogenic acid is an important bioactive substance, and has antibacterial, antiviral, leukocyte increasing, liver protecting, gallbladder promoting, antitumor, blood pressure lowering, blood lipid reducing, free radical scavenging, and central nervous system exciting effects.
If chlorogenic acid can be added into coffee to make the coffee into functional coffee, the coffee is more beneficial to the efficacy of a human body. However, if chlorogenic acid is added to coffee, the solubility of coffee is reduced, which affects its organoleptic qualities.
Disclosure of Invention
The invention aims to provide a processing method of functional coffee based on chlorogenic acid, aiming at the problem that the solubility of functional component chlorogenic acid in coffee is reduced in the prior art.
Another object of the invention is to provide a functional coffee obtained by said process.
The technical scheme adopted for realizing the purpose of the invention is as follows:
a processing method of functional coffee based on chlorogenic acid comprises the following steps:
step 1, shearing coffee concentrated solution by utilizing shearing equipment;
step 2, freeze-drying the coffee concentrated solution after the shearing treatment to obtain freeze-dried coffee;
and 3, mixing the freeze-dried coffee obtained in the step 2 with chlorogenic acid or a plant extract containing the chlorogenic acid to prepare the functional coffee.
In the technical scheme, the chlorogenic acid-containing plant extract is a honeysuckle extract, and the chlorogenic acid content in the honeysuckle extract is 10-95%.
In the above technical scheme, in the step 1, the solid content in the coffee concentrated solution is 5% -15%.
In the above technical solution, in the step 1, the shearing device is a high-speed shearing machine.
In the above technical solution, in the step 1, the rotation speed of the shearing treatment is 2000r/min to 20000r/min, preferably 10000r/min to 15000r/min, more preferably 12000r/min to 14500r/min, and the time of the shearing treatment is 2min to 20min, preferably 10min to 20min, more preferably 12min to 14 min. As the solids content of the coffee concentrate increases, the rotation speed of the shearing process should be increased accordingly in order to obtain a better shearing effect.
In the technical scheme, in the step 1, the shearing treatment is carried out in a vacuum environment, and the vacuum degree is-0.08 MPa to-0.1 MPa, so that excessive foams are prevented from being generated in the shearing process.
In the above technical solution, in the step 1, the shearing treatment is performed in a low temperature environment, the temperature is 2 to 6 ℃, so as to prevent the heat generated in the shearing process from affecting the sensory quality of the coffee.
In the technical scheme, in the step 2, the mixture is pre-frozen for 12 to 24 hours at the temperature of between 0 and 6 ℃ below zero, and then is freeze-dried in a freeze dryer at the temperature of between 40 and 50 ℃ below zero for 24 to 48 hours.
In another aspect of the present invention, a functional coffee comprises the freeze-dried coffee and chlorogenic acid or a plant extract containing chlorogenic acid, wherein the freeze-dried coffee is prepared according to the steps 1 and 2.
In the technical scheme, the mass of the chlorogenic acid added into each 2.5g of the functional freeze-dried coffee or the chlorogenic acid extracted from the plants is 10-1000 mg, the solubility and the taste of the chlorogenic acid are comprehensively considered, and the mass of the chlorogenic acid added into each 2.5g of the functional freeze-dried coffee or the chlorogenic acid extracted from the plants is 10-400 mg.
Compared with the prior art, the invention has the beneficial effects that:
1. the coffee concentrated solution can increase the solubility of functional component chlorogenic acid after shearing, the coffee concentrated solution without shearing is re-dissolved after freeze-drying, the solubility of chlorogenic acid in the obtained dissolved solution is 2.6%, the coffee concentrated solution after shearing is re-dissolved after freeze-drying, and the solubility of chlorogenic acid in the obtained dissolved solution is 4%.
2. Shearing the coffee concentrated solution, freeze-drying, adding chlorogenic acid or an extract containing chlorogenic acid to obtain functional coffee, wherein the dissolution speed of the obtained functional coffee is high, the dissolution speed of the uncut coffee concentrated solution is 1min39s for the chlorogenic acid added after freeze-drying, and the dissolution speed of the sheared coffee concentrated solution and the chlorogenic acid added after freeze-drying is only 51s for the functional coffee.
3. Compared with the coffee which is not processed, the aroma of the cut coffee is stronger, which shows that the sensory characteristics of the coffee can be improved by adding the chlorogenic acid after the cutting processing.
4. After functional component chlorogenic acid is added, the coffee can obviously reduce MDA, oxidation resistance and enhance immunity.
Drawings
Figure 1 is the solubility of chlorogenic acid for each example.
FIG. 2 is the MDA content in liver of example 11.
FIG. 3 shows the MDA content in serum of example 11.
FIG. 4 is the GSH-PX activity of liver tissue in example 11.
FIG. 5 is the immune organ index in example 11.
Detailed Description
The present invention will be described in further detail with reference to specific examples. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
Example 1
1.1
A processing method of functional coffee based on chlorogenic acid comprises the following steps:
step 1, taking 50mL of coffee concentrated solution with the concentration of 10 percent, placing the coffee concentrated solution into a conical flask, marking the coffee concentrated solution as a shearing group 1, and treating the coffee concentrated solution for 6min at the rotating speed of 12000r/min by using a high-speed shearing machine;
and 2, pre-freezing the sheared coffee concentrated solution obtained in the step 1 at-80 ℃ for 12h, and then performing freeze-drying in a freeze dryer at-40 ℃ for 48h to obtain freeze-dried powder, namely the freeze-dried coffee.
And 3, adding a honeysuckle extract into the freeze-dried coffee obtained in the step 2, and uniformly mixing to obtain the functional coffee.
The mass of the honeysuckle extract added into each 2.5g of the functional freeze-dried coffee is 100mg, wherein the chlorogenic acid content in the honeysuckle extract is 10%.
1.2
And (3) re-dissolving the freeze-dried coffee obtained in the step (2) to obtain a coffee dissolved solution, dissolving excessive chlorogenic acid in the coffee dissolved solution, standing, centrifuging, removing a supernatant, drying a precipitate, and weighing, wherein the solubility of the chlorogenic acid in the embodiment is 2.8%.
Example 2
2.1
A processing method of functional coffee based on chlorogenic acid comprises the following steps:
step 1, 50mL of coffee concentrate at 10% concentration is placed in a conical flask, labeled as cut group 2, and treated with a high speed shearer at 12000r/min for 8 min.
And 2, pre-freezing the sheared coffee concentrated solution obtained in the step 1 at-80 ℃ for 12h, and then freeze-drying the coffee concentrated solution in a freeze dryer at-40 ℃ for 48h to obtain freeze-dried powder, namely the freeze-dried coffee.
And 3, adding solid chlorogenic acid into the freeze-dried coffee obtained in the step 2, and uniformly mixing to obtain the functional coffee.
The mass of the honeysuckle extract added into each 2.5g of the functional freeze-dried coffee is 300mg, wherein the chlorogenic acid content in the honeysuckle extract is 10%.
2.2
And (3) re-dissolving the freeze-dried coffee obtained in the step (2) to obtain a coffee dissolved solution, dissolving excessive chlorogenic acid in the coffee dissolved solution, standing, centrifuging, removing a supernatant, drying a precipitate, and weighing to obtain the chlorogenic acid solubility of the embodiment of 2.7%.
Example 3
A processing method of functional coffee based on chlorogenic acid comprises the following steps:
step 1, 50mL of coffee concentrate with a concentration of 10% is taken and placed in an Erlenmeyer flask, marked as cut group 3, and treated with a high speed shearer at a rotation speed of 12000r/min for 10 min.
And 2, pre-freezing the sheared coffee obtained in the step 1 at-80 ℃ for 12h, and then freeze-drying the sheared coffee in a freeze dryer at-40 ℃ for 48h to obtain freeze-dried powder, namely the freeze-dried coffee.
And 3, adding solid chlorogenic acid into the freeze-dried coffee obtained in the step 2, and uniformly mixing to obtain the functional coffee.
The mass of the honeysuckle extract added into each 2.5g of the functional freeze-dried coffee is 700mg, wherein the chlorogenic acid content in the honeysuckle extract is 10%.
3.2
And (3) re-dissolving the freeze-dried coffee obtained in the step (2) to obtain a coffee dissolved solution, dissolving excessive chlorogenic acid in the coffee dissolved solution, standing, centrifuging, removing a supernatant, drying a precipitate, and weighing to obtain the chlorogenic acid solubility of the embodiment of 3.1%.
Example 4
4.1
A method for processing functional coffee based on chlorogenic acid comprises the following steps:
step 1, 50mL of coffee concentrate with a concentration of 10% is taken and placed in an Erlenmeyer flask, marked as cut group 4, and treated with a high speed shearer at a rotation speed of 12000r/min for 12 min.
And 2, pre-freezing the sheared coffee concentrated solution obtained in the step 1 at-80 ℃ for 12h, and then freeze-drying the coffee concentrated solution in a freeze dryer at-40 ℃ for 48h to obtain freeze-dried powder, namely the freeze-dried coffee.
And 3, adding solid chlorogenic acid into the freeze-dried coffee obtained in the step 2, and uniformly mixing to obtain the functional coffee.
The mass of the honeysuckle extract added into each 2.5g of the functional freeze-dried coffee is 900mg, wherein the chlorogenic acid content in the honeysuckle extract is 10%.
4.2
And (3) re-dissolving the freeze-dried coffee obtained in the step (2) to obtain a coffee dissolved solution, dissolving excessive chlorogenic acid in the coffee dissolved solution, standing, centrifuging, removing a supernatant, drying a precipitate, and weighing to obtain the chlorogenic acid solubility of the embodiment of 3.3%.
Example 5
5.1
A processing method of functional coffee based on chlorogenic acid comprises the following steps:
step 1, taking 50mL of coffee concentrated solution with the concentration of 10% and placing the coffee concentrated solution into a conical flask, marking the coffee concentrated solution as a shearing group 5, treating the coffee concentrated solution for 14min at the rotating speed of 12000r/min by using a high-speed shearing machine, and measuring the particle size of the coffee concentrated solution after shearing treatment to be about 1080 nm.
And 2, pre-freezing the sheared coffee concentrated solution obtained in the step 1 at-80 ℃ for 12h, and then freeze-drying the coffee concentrated solution in a freeze dryer at-40 ℃ for 48h to obtain freeze-dried powder, namely the freeze-dried coffee.
And 3, adding solid chlorogenic acid into the freeze-dried coffee obtained in the step 2, and uniformly mixing to obtain the functional coffee.
The mass of the honeysuckle extract added in each 2.5g of the functional freeze-dried coffee is 1g, wherein the chlorogenic acid content in the honeysuckle extract is 10%.
5.2
And (3) re-dissolving the freeze-dried coffee obtained in the step (2) to obtain a coffee dissolved solution, dissolving excessive chlorogenic acid in the coffee dissolved solution, standing, centrifuging, removing a supernatant, drying a precipitate, and weighing to obtain the chlorogenic acid solubility of the embodiment of 3.0%.
Example 6
6.1
A processing method of functional coffee based on chlorogenic acid comprises the following steps:
step 1, 50mL of coffee concentrate with a concentration of 10% is taken and placed in an Erlenmeyer flask, marked as cut group 6, and treated with a high speed shearer at a rotation speed of 14500r/min for 6 min.
And 2, pre-freezing the sheared coffee concentrated solution obtained in the step 1 at-80 ℃ for 12h, and then freeze-drying the coffee concentrated solution in a freeze dryer at-40 ℃ for 48h to obtain freeze-dried powder, namely the freeze-dried coffee.
And 3, adding solid chlorogenic acid into the freeze-dried coffee obtained in the step 2, and uniformly mixing to obtain the functional coffee.
The mass of the honeysuckle extract added in each 2.5g of the functional freeze-dried coffee is 1.5g, wherein the chlorogenic acid content in the honeysuckle extract is 10%.
6.2
And (3) re-dissolving the freeze-dried coffee obtained in the step (2) to obtain a coffee dissolved solution, dissolving excessive chlorogenic acid in the coffee dissolved solution, standing, centrifuging, removing a supernatant, drying a precipitate, and weighing to obtain the chlorogenic acid solubility of the embodiment of 3.0%.
Example 7
7.1
A processing method of functional coffee based on chlorogenic acid comprises the following steps:
step 1, 50mL of coffee concentrate at 10% concentration is placed in an Erlenmeyer flask, labeled as cut group 7, and treated with a high speed cutter at 14500r/min for 8 min.
And 2, pre-freezing the sheared coffee concentrated solution obtained in the step 1 at-80 ℃ for 12h, and then freeze-drying the coffee concentrated solution in a freeze dryer at-40 ℃ for 48h to obtain freeze-dried powder, namely the freeze-dried coffee.
And 3, adding solid chlorogenic acid into the freeze-dried coffee obtained in the step 2, and uniformly mixing to obtain the functional coffee.
The mass of the honeysuckle extract added in each 2.5g of the functional freeze-dried coffee is 2g, wherein the chlorogenic acid content in the honeysuckle extract is 10%.
7.2
And (3) re-dissolving the freeze-dried coffee obtained in the step (2) to obtain a coffee dissolved solution, dissolving excessive chlorogenic acid in the coffee dissolved solution, standing, centrifuging, removing a supernatant, drying a precipitate, and weighing to obtain the chlorogenic acid solubility of the embodiment of 3.5%.
Example 8
8.1
A processing method of functional coffee based on chlorogenic acid comprises the following steps:
step 1, 50mL of coffee concentrate at 10% concentration is placed in a conical flask, labeled as sheared set 8, and treated with a high speed shearer at 14500r/min for 10 min.
And 2, pre-freezing the sheared coffee concentrated solution obtained in the step 1 at-80 ℃ for 12h, and then freeze-drying the coffee concentrated solution in a freeze dryer at-40 ℃ for 48h to obtain freeze-dried powder, namely the freeze-dried coffee.
And 3, adding solid chlorogenic acid into the freeze-dried coffee obtained in the step 2, and uniformly mixing to obtain the functional coffee.
The mass of the honeysuckle extract added in each 2.5g of the functional freeze-dried coffee is 2.5g, wherein the chlorogenic acid content in the honeysuckle extract is 10%.
8.2
And (3) re-dissolving the freeze-dried coffee obtained in the step (2) to obtain a coffee dissolved solution, dissolving excessive chlorogenic acid in the coffee dissolved solution, standing, centrifuging, removing a supernatant, drying a precipitate, and weighing to obtain the chlorogenic acid solubility of the embodiment of 3.2%.
Example 9
9.1
A processing method of functional coffee based on chlorogenic acid comprises the following steps:
step 1, 50mL of coffee concentrate at 10% concentration is placed in an Erlenmeyer flask, labeled as cut group 9, and treated with a high speed cutter at 14500r/min for 12 min.
And 2, pre-freezing the sheared coffee concentrated solution obtained in the step 1 at-80 ℃ for 12h, and then freeze-drying the coffee concentrated solution in a freeze dryer at-40 ℃ for 48h to obtain freeze-dried powder, namely the freeze-dried coffee.
And 3, adding solid chlorogenic acid into the freeze-dried coffee obtained in the step 2, and uniformly mixing to obtain the functional coffee.
The mass of the honeysuckle extract added in each 2.5g of the functional freeze-dried coffee is 4g, wherein the chlorogenic acid content in the honeysuckle extract is 10%.
9.2
And (3) re-dissolving the freeze-dried coffee obtained in the step (2) to obtain a coffee dissolved solution, dissolving excessive chlorogenic acid in the coffee dissolved solution, standing, centrifuging, removing a supernatant, drying a precipitate, and weighing to obtain chlorogenic acid solubility of 4.0% in the embodiment.
Example 10
10.1
A processing method of functional coffee based on chlorogenic acid comprises the following steps:
step 1, 50mL of coffee concentrate at 10% concentration is placed in an Erlenmeyer flask, labeled as cut group 10, and processed with a high speed cutter at 14500r/min for 14 min.
And 2, pre-freezing the sheared coffee concentrated solution obtained in the step 1 at-80 ℃ for 12h, and then freeze-drying the coffee concentrated solution in a freeze dryer at-40 ℃ for 48h to obtain freeze-dried powder, namely the freeze-dried coffee.
And 3, adding solid chlorogenic acid into the freeze-dried coffee obtained in the step 2, and uniformly mixing to obtain the functional coffee.
The mass of the honeysuckle extract added into each 2.5g of the functional freeze-dried coffee is 3g, wherein the chlorogenic acid content in the honeysuckle extract is 10%.
10.2
And (3) re-dissolving the freeze-dried coffee obtained in the step (2) to obtain a coffee dissolved solution, dissolving excessive chlorogenic acid in the coffee dissolved solution, standing, centrifuging, removing a supernatant, drying a precipitate, and weighing to obtain chlorogenic acid solubility of 4.2% in the embodiment.
Comparative example
Step 1, taking 50mL of coffee concentrated solution with the concentration of 10% and placing the coffee concentrated solution in a conical flask, and marking the coffee concentrated solution as an uncut group;
and 2, pre-freezing the coffee concentrated solution at-80 ℃ for 12h, and then freeze-drying the coffee concentrated solution at-40 ℃ for 48h in a freeze dryer to obtain freeze-dried powder, namely the freeze-dried coffee.
And step 3: dissolving excessive chlorogenic acid in coffee dissolving solution, standing, centrifuging, discarding supernatant, oven drying precipitate, and weighing to obtain chlorogenic acid solubility of 2.6%.
TABLE 1
Shear conditions Solubility of chlorogenic acid
Example 1 12000r/min 6min 2.8%
Example 2 12000r/min 8min 2.7%
Example 3 12000r/min 10min 3.1%
Example 4 12000r/min 12min 3.3%
Example 5 12000r/min 14min 3.0%
Example 6 14500r/min 6min 3.0%
Example 7 14500r/min 8min 3.5%
Example 8 14500r/min 10min 3.2%
Example 9 14500r/min 12min 4.0%
Example 10 14500r/min 14min 4.2%
Comparative example 1 Without shearing 2.6%
As analyzed from table 1, the solubility of chlorogenic acid of the examples showed a tendency to increase, as shown in fig. 1, with increasing time the coffee concentrate subjected to shearing treatment had a certain increase in the solubility of chlorogenic acid. During the shearing process of the coffee concentrated solution, macromolecules are converted into micromolecules, and more hydrophobic groups are exposed on solid matters in the coffee concentrated solution and can be combined with more chlorogenic acid.
In example 10, part of the aroma components were lost during the shearing process, so that the shearing conditions in example 9 were better than those in example 10 after comprehensive judgment. 1g of freeze-dried coffee obtained in the step 2 of the example 9 is taken and added with 200mg of chlorogenic acid, and the obtained functional coffee is dissolved in 100ml of water for 51 s; 1g of freeze-dried coffee obtained in step 2 of the comparative example was taken, 200mg of chlorogenic acid was added, and the obtained functional coffee was dissolved in 100ml of water, which required 1min39 s.
Example 11
To further study the effect of chlorogenic acid, animal experiments were performed.
The coffee liquid in this example is a solution obtained by dissolving 2g of the freeze-dried coffee powder obtained in step 2 of example 9 in 200 mL. The chlorogenic acid is commercially pure chlorogenic acid powder, wherein the following D-galactose is 120mg/kg, the gavage amount of the mouse is mouse weight (kg) by 120mg/kg, and similarly, the chlorogenic acid is 100mg/kg, the gavage amount of the mouse is mouse weight (kg) by 100 mg/kg.
1) Normal control group: basal feed, free water intake. Intragastric lavage liquid 0.2mL per day
2) Model control group: basal feed, free water intake. Gavage D-galactose 120mg/kg 0.2mL per day
3) Positive control group: basal feed, free water intake. Gavage D-galactose 120mg/kg and Vc100mg/kg 0.2mL each day
4) Coffee control group: basal feed, free water intake. Gavage 120mg/kg D-galactose and 0.2mL coffee liquid every day
5) Chlorogenic acid high dose experimental group: basal feed, free water intake. Gavage 120mg/kg of D-galactose, chlorogenic acid 200mg/kg and 0.2mL of coffee solution every day
6) Chlorogenic acid medium dose experimental group: basal feed, free water intake. Per day gavage of D-galactose 120mg/kg, chlorogenic acid 100mg/kg, and 0.2mL coffee solution
7) Chlorogenic acid low dose experimental group: basal feed, free water intake. Gavage 120mg/kg of D-galactose and chlorogenic acid 50mg/kg and 0.2mL of coffee liquid every day
Remarking: the group with coffee is to dissolve the drug in coffee for gastric perfusion.
Healthy adult Kunming male mice (26g +/-2 g) with the age of three months are selected, are fed with food and water naturally day and night freely, are randomly divided into 7 groups and 10 groups according to the body weight after adaptive feeding for 7 days, and a D-galactose model is used. And evaluating the antioxidant effect of the tested sample on the levels of malondialdehyde, SOD and GSH-Px and the content of hemoglobin and total protein of the D-galactose model animal.
Establishing an animal model: by continuously administering D-galactose to animals in large quantities, the intracellular galactose concentration in the animals is increased and reduced to galactitol by aldose reductase. Galactitol can not be further metabolized by cells and is accumulated in cells, so that the normal sugar metabolism balance of the cells is broken, and aging is caused.
Weighing body weight regularly, collecting blood or preparing tissue homogenate after 30 days, and measuring animal malondialdehyde, SOD, CSH-Px levels, hemoglobin and total protein content and organ index change.
The index measuring method comprises the following steps:
1) blood routine: blood routine of each group of animals
2) ELISA: the contents of malondialdehyde, SOD and CSH-Px in the serum and liver homogenates of each group were determined (5 per group, no multiple wells; total 70 samples)
3) Change in organ index: at the end of the experiment, 5 mice were randomly selected per group, fasted for 12h, weighed, slaughtered, spleen and thymus isolated and weighed, and immune organ index calculated.
Immune organ index (g/kg) is immune organ weight (g)/pre-slaughter live weight (kg).
As shown in figure 2, MDA is the major product of lipid peroxidation, with lower levels of MDA indicating less lipid peroxidation and less oxidative damage. In the liver, the MDA content of the chlorogenic acid group is obviously lower than that of a normal control group and a model control group, which shows that the chlorogenic acid has an improvement effect on the antioxidant function of the mouse. The MDA content in the liver of the chlorogenic acid group is lower than that of the coffee control group, which shows that the effect of adding the chlorogenic acid is better than that of pure coffee.
As shown in fig. 3, in the serum, the content of the chlorogenic acid group MDA is significantly lower than that of other control groups, which indicates that the chlorogenic acid can significantly reduce the content of the MDA in the serum and improve the antioxidant capacity of mice, while the chlorogenic acid has the lowest content of the MDA in the chlorogenic acid group, which indicates that the chlorogenic acid has an optimal concentration of 100 mg/kg. The MDA content in the serum of the chlorogenic acid group is lower than that of the coffee control group, which indicates that the effect of adding the chlorogenic acid is due to the effect of pure coffee.
As shown in FIG. 4, the antioxidant enzyme can effectively remove the free radicals generated by foreign body metabolism, and GSH GSH-Px and SOD are present in all oxygen-metabolized cells as antioxidant enzymes of a free radical removal system, so as to prevent from being damaged by the free radicals and provide a repair mechanism for oxidized cell membranes. In the liver, the activity of GSH GSH-PX in the chlorogenic acid group is higher than that in the model control group, which shows that the chlorogenic acid has the effect, and the effect in the medium dose group is the best.
As shown in FIG. 5, thymus and spleen are the major immune organs, reflecting the level of oxidative damage during aging. Compared with the normal group, the chlorogenic acid is improved compared with the spleen and thymus index of the model control, which indicates that the atrophy of internal organs of a mouse can be delayed, and the immunity is enhanced. The immune organ index is higher than that of the coffee control group, which indicates that the effect of adding chlorogenic acid is that pure coffee is used.
In conclusion, 100mg/kg is the optimal amount, that is, 3mg of chlorogenic acid is added into 0.2mL of coffee liquid to achieve the optimal effects of reducing MDA, resisting oxidation and enhancing immunity.
The foregoing is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, various modifications and decorations can be made without departing from the principle of the present invention, and these modifications and decorations should also be regarded as the protection scope of the present invention.

Claims (10)

1. A processing method of functional coffee based on chlorogenic acid is characterized by comprising the following steps:
step 1, shearing coffee concentrated solution by utilizing shearing equipment;
step 2, freeze-drying the coffee concentrated solution after the shearing treatment to obtain freeze-dried coffee;
and 3, mixing the freeze-dried coffee obtained in the step 2 with chlorogenic acid or a plant extract containing the chlorogenic acid to prepare the functional coffee.
2. The process of claim 1, wherein in step 1, the coffee concentrate has a solids content of 5% to 15%.
3. The process of claim 1, wherein in step 1, the shearing device is a high speed shear.
4. The process according to claim 1, wherein in the step 1, the rotation speed of the shearing treatment is 2000r/min to 20000r/min, preferably 10000r/min to 15000r/min, more preferably 12000r/min to 14500r/min, and the time of the shearing treatment is 2min to 20min, preferably 10min to 20min, more preferably 12min to 14 min.
5. The process according to claim 1, wherein the shearing treatment in step 1 is carried out in a vacuum atmosphere at a vacuum degree of-0.08 MPa to-0.1 MPa.
6. The process of claim 1, wherein in step 1, the shearing treatment is carried out in a low temperature environment at a temperature of 2 ℃ to 6 ℃.
7. The process of claim 1, wherein in step 2, the mixture is pre-frozen at 0 ℃ to-6 ℃ for 12h to 24h, and then freeze-dried in a freeze-dryer at-40 ℃ to-50 ℃ for 24h to 48 h.
8. The processing method of claim 1, wherein in step 3, the chlorogenic acid-containing plant extract is a honeysuckle extract, and the chlorogenic acid content in the honeysuckle extract is 10-95%.
9. A functional coffee comprising freeze-dried coffee and chlorogenic acid or a plant extract containing chlorogenic acid, said freeze-dried coffee being prepared according to steps 1 and 2 of the process according to any of claims 1 to 8.
10. The functional coffee according to claim 9, wherein the mass of chlorogenic acid added per 2.5g of functional coffee or chlorogenic acid in the plant extract is 10mg to 1000mg, preferably 10mg to 400mg per 2.5g of functional coffee.
CN202210342954.5A 2022-03-31 2022-04-02 Functional coffee and processing method thereof Pending CN114631586A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202210333159 2022-03-31
CN202210333159X 2022-03-31

Publications (1)

Publication Number Publication Date
CN114631586A true CN114631586A (en) 2022-06-17

Family

ID=81952685

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210342954.5A Pending CN114631586A (en) 2022-03-31 2022-04-02 Functional coffee and processing method thereof

Country Status (1)

Country Link
CN (1) CN114631586A (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005333927A (en) * 2004-05-28 2005-12-08 Ajinomoto General Foods Inc Chlorogenic acid-containing drink
US20060035000A1 (en) * 2004-08-10 2006-02-16 Bunke Paul R Soluble coffee product having improved flavor and aroma
CN102711504A (en) * 2009-10-01 2012-10-03 希克马特·瓦迪·沙欣 Coffee composition consisting of soluble, freeze-dried and finely ground natural roasted coffee which has the taste and aroma of freshly roasted natural coffee, and method for producing said composition
CN103096727A (en) * 2010-07-16 2013-05-08 卡夫食品研发公司 Coffee products and related processes
CN103917102A (en) * 2011-11-04 2014-07-09 卡夫食品研究和开发股份有限公司 Processes for forming soluble coffee products
CN104256025A (en) * 2014-09-19 2015-01-07 重庆市中药研究院天然保健制品厂 Traditional Chinese medicine coffee with functions of improving immunity and relieving fatigue, and preparation method thereof
CN105248792A (en) * 2015-11-11 2016-01-20 济南舜祥医药科技有限公司 Coffee containing honeysuckle flower extract

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005333927A (en) * 2004-05-28 2005-12-08 Ajinomoto General Foods Inc Chlorogenic acid-containing drink
US20060035000A1 (en) * 2004-08-10 2006-02-16 Bunke Paul R Soluble coffee product having improved flavor and aroma
CN102711504A (en) * 2009-10-01 2012-10-03 希克马特·瓦迪·沙欣 Coffee composition consisting of soluble, freeze-dried and finely ground natural roasted coffee which has the taste and aroma of freshly roasted natural coffee, and method for producing said composition
CN103096727A (en) * 2010-07-16 2013-05-08 卡夫食品研发公司 Coffee products and related processes
CN103917102A (en) * 2011-11-04 2014-07-09 卡夫食品研究和开发股份有限公司 Processes for forming soluble coffee products
CN104256025A (en) * 2014-09-19 2015-01-07 重庆市中药研究院天然保健制品厂 Traditional Chinese medicine coffee with functions of improving immunity and relieving fatigue, and preparation method thereof
CN105248792A (en) * 2015-11-11 2016-01-20 济南舜祥医药科技有限公司 Coffee containing honeysuckle flower extract

Similar Documents

Publication Publication Date Title
US10820612B2 (en) Method for producing fermented bamboo extract and immunostimulating agent
KR102432654B1 (en) Feed additives for improve joint disease in companion animal
Treviño et al. Effect of tannins from faba beans (Vicia faba) on the digestion of starch by growing chicks
CN101199323A (en) Formaldehyde scavenger for sleeve-fish and its application method
CN112715957A (en) Biological small molecular peptide composition for dispelling effects of alcohol and protecting liver and preparation method thereof
Kunyanga et al. Nutritional quality, phytochemical composition and health protective effects of an under-utilized prickly cactus fruit (Opuntia stricta Haw.) collected from Kenya
KR101904702B1 (en) Composition for immune enhancement and method the same
KR102348278B1 (en) health food composition manufacturing method including antler, Yagwanmun, Yonganyuk and Gugija, health food composition manufactured by the same
US7214393B2 (en) Anti-allergy composition comprising wood vinegar- or bamboo vinegar-distilled solution
CN104705539B (en) A kind of composite formaldehyde remover and its application process for sleeve-fish product
CN114631586A (en) Functional coffee and processing method thereof
KR100793815B1 (en) Method for removing toxic ingredients
Qamar et al. Recovery of Chickens Affected with Tibial Dyschondroplasia by Application of Grape Seed Extract through Downregulating CA2 Gene and Enhancing Liver Functions.
CN106720801B (en) Burdock tea rich in inulin
CN111713666B (en) Fat reducing composition and preparation method thereof
KR102333548B1 (en) Animal feed composition comprising bass extract and preparation method thereof
CN114468034A (en) Method for improving bioavailability of selenium in selenium-rich rape land
JPH1075750A (en) Garlic-based health beverage
KR101918890B1 (en) Pollen Fermented liquid composition using glacial water and method of producing the same
Hadakar et al. Changes in total phenolics and antioxidant activities in the developing fruits of mango
US20040018254A1 (en) Synergistic compositions from yeast-modified aqueous extracts from almond hulls
CN101999564A (en) Composite formaldehyde inhibitor of sleeve-fish product and application method thereof
Tias et al. Antioxidant Activity Test of Sungkai Leaf (Peronema canescens Jack) Steeping Drink with the Addition of Honey
CN113785873B (en) Natural shrimp blackening preventing agent and preparation method and application thereof
CN114128853B (en) Green fruit and vegetable powder with stable color and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination